Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.81 - $1.44 $43,585 - $77,484
-53,809 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$1.3 - $4.19 $4,578 - $14,757
3,522 Added 7.0%
53,809 $82,000
Q4 2021

Feb 14, 2022

SELL
$3.81 - $6.17 $15,990 - $25,895
-4,197 Reduced 7.7%
50,287 $186,000
Q3 2021

Nov 12, 2021

BUY
$6.02 - $12.46 $86,832 - $179,723
14,424 Added 36.01%
54,484 $392,000
Q2 2021

Aug 16, 2021

BUY
$9.62 - $14.56 $179,364 - $271,471
18,645 Added 87.07%
40,060 $442,000
Q1 2021

May 17, 2021

BUY
$11.2 - $27.8 $239,847 - $595,337
21,415 New
21,415 $275,000

About Talis Biomedical Corp


  • Ticker TLIS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 26,619,200
  • Market Cap $47.1M
  • Description
  • Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis One COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVID-19. ...
More about TLIS
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.